Pharmazon has received a minority investment from a private investor
The shareholders of Pharmazon have sold the company to a private investor.
Pharmazon is a B2B distributor of OTC and parapharmacy products to French pharmacies. Its core business is to buy products directly from laboratories, negotiating good conditions and selling them online through a modern website which looks similar to Amazon.com.
The company's shareholders are the CEO and General Director.
Oaklins' team in France advised the seller in this transaction.
Sprechen Sie mit dem Deal-Team
GeneTech Inc. has been acquired by Eurofins
Noritsu Koki Ltd. has sold GeneTech Inc. to Eurofins Clinical Testing Holding Lux S.à r.l.Mehr erfahren
MediCa group has been acquired by Repharm
CGP Management has sold MediCa group, the largest private provider of healthcare services in Lithuania, to Repharm.Mehr erfahren
The MOLE Clinic Limited has been acquired by Sk:n (backed by TriSpan)
The shareholders of The MOLE Clinic Limited have sold the company to Sk:n.Mehr erfahren